129 related articles for article (PubMed ID: 38112973)
1. Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein.
Iliopoulou K; Koufargyris P; Doulou S; Tasouli E; Katopodis S; Chachali SP; Schinas G; Karachalios C; Astriti M; Katsaounou P; Chrysos G; Seferlis T; Dimopoulou E; Kollia M; Poulakou G; Gerakari S; Papanikolaou IC; Milionis H; Dalekos GN; Tzavara V; Kontopoulou T; Giamarellos-Bourboulis EJ
Infect Dis Ther; 2024 Jan; 13(1):105-119. PubMed ID: 38112973
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection.
Sambursky R; Shapiro N
Eur Clin Respir J; 2015; 2():28245. PubMed ID: 26672961
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of viral infections using myxovirus resistance protein A (MxA).
Engelmann I; Dubos F; Lobert PE; Houssin C; Degas V; Sardet A; Decoster A; Dewilde A; Martinot A; Hober D
Pediatrics; 2015 Apr; 135(4):e985-93. PubMed ID: 25802344
[TBL] [Abstract][Full Text] [Related]
4. Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection.
Piri R; Yahya M; Ivaska L; Toivonen L; Lempainen J; Nuolivirta K; Tripathi L; Waris M; Peltola V
Microbiol Spectr; 2022 Feb; 10(1):e0203121. PubMed ID: 35080443
[TBL] [Abstract][Full Text] [Related]
5. Performance of the FebriDx Rapid Point-of-Care Test for Differentiating Bacterial and Viral Respiratory Tract Infections in Patients with a Suspected Respiratory Tract Infection in the Emergency Department.
Tong-Minh K; Daenen K; Endeman H; Ramakers C; Gommers D; van Gorp E; van der Does Y
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202172
[TBL] [Abstract][Full Text] [Related]
6. Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.
Joseph P; Godofsky E
Open Forum Infect Dis; 2018 Feb; 5(2):ofy024. PubMed ID: 29479553
[TBL] [Abstract][Full Text] [Related]
7. Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children - The TREND study.
Rhedin S; Eklundh A; Ryd-Rinder M; Peltola V; Waris M; Gantelius J; Lindh M; Andersson M; Gaudenzi G; Mårtensson A; Naucler P; Alfvén T
Clin Microbiol Infect; 2022 Sep; 28(9):1251-1257. PubMed ID: 35597507
[TBL] [Abstract][Full Text] [Related]
8. MxA for differentiating viral and bacterial infections in adults: a prospective, exploratory study.
Metz M; Gualdoni GA; Winkler HM; Warenits AM; Stöckl J; Burgmann H; Winkler S; Oesterreicher ZA
Infection; 2023 Oct; 51(5):1329-1337. PubMed ID: 36737561
[TBL] [Abstract][Full Text] [Related]
9. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study.
van Houten CB; de Groot JAH; Klein A; Srugo I; Chistyakov I; de Waal W; Meijssen CB; Avis W; Wolfs TFW; Shachor-Meyouhas Y; Stein M; Sanders EAM; Bont LJ
Lancet Infect Dis; 2017 Apr; 17(4):431-440. PubMed ID: 28012942
[TBL] [Abstract][Full Text] [Related]
10. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.
Shapiro NI; Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Sambursky R
Ann Med; 2018 Aug; 50(5):420-429. PubMed ID: 29775092
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections.
Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Shapiro NI
J Clin Med; 2017 Oct; 6(10):. PubMed ID: 28991170
[TBL] [Abstract][Full Text] [Related]
12. Blood myxovirus resistance protein-1 measurement in the diagnostic work-up of suspected COVID-19 infection in the emergency department.
Tong-Minh K; van Hooijdonk S; Versnel MA; van Helden-Meeuwsen CG; van Hagen PM; van Gorp ECM; Endeman H; van der Does Y; Dalm VASH; Dik WA
Immun Inflamm Dis; 2022 Apr; 10(4):e609. PubMed ID: 35349755
[TBL] [Abstract][Full Text] [Related]
13. Blood MxA protein as a marker for respiratory virus infections in young children.
Toivonen L; Schuez-Havupalo L; Rulli M; Ilonen J; Pelkonen J; Melen K; Julkunen I; Peltola V; Waris M
J Clin Virol; 2015 Jan; 62():8-13. PubMed ID: 25542463
[TBL] [Abstract][Full Text] [Related]
14. Performance Evaluation of Host Biomarker Combinations for the Diagnosis of Serious Bacterial Infection in Young Febrile Children: A Double-Blind, Multicentre, Observational Study.
Portefaix A; Pons S; Ouziel A; Basmaci R; Rebaud P; Delafay MC; Generenaz L; Oriol G; Meunier B; Abbas-Chorfa F; Trouillet-Assant S; Ginhoux T; Subtil F; Gillet Y; Brengel-Pesce K; Javouhey E
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362791
[TBL] [Abstract][Full Text] [Related]
15. Interferon-Inducible Myxovirus Resistance Proteins: Potential Biomarkers for Differentiating Viral from Bacterial Infections.
Zav'yalov VP; Hämäläinen-Laanaya H; Korpela TK; Wahlroos T
Clin Chem; 2019 Jun; 65(6):739-750. PubMed ID: 30593466
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of respiratory viruses and antiviral MxA responses in children with febrile urinary tract infection.
Piri R; Ivaska L; Yahya M; Toivonen L; Lempainen J; Kataja J; Nuolivirta K; Tripathi L; Waris M; Peltola V
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1239-1244. PubMed ID: 32048070
[TBL] [Abstract][Full Text] [Related]
17. Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection.
Ivaska L; Niemelä J; Lempainen J; Österback R; Waris M; Vuorinen T; Hytönen J; Rantakokko-Jalava K; Peltola V
J Infect; 2017 Apr; 74(4):385-392. PubMed ID: 28077283
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of a Bacterial and Viral Biomarker Point-of-Care Test in the Outpatient Setting.
Shapiro NI; Filbin MR; Hou PC; Kurz MC; Han JH; Aufderheide TP; Ward MA; Pulia MS; Birkhahn RH; Diaz JL; Hughes TL; Harsch MR; Bell A; Suarez-Cuervo C; Sambursky R
JAMA Netw Open; 2022 Oct; 5(10):e2234588. PubMed ID: 36255727
[TBL] [Abstract][Full Text] [Related]
19. A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study.
Papan C; Argentiero A; Porwoll M; Hakim U; Farinelli E; Testa I; Pasticci MB; Mezzetti D; Perruccio K; Etshtein L; Mastboim N; Moscoviz E; Ber TI; Cohen A; Simon E; Boico O; Shani L; Gottlieb TM; Navon R; Barash E; Oved K; Eden E; Simon A; Liese JG; Knuf M; Stein M; Yacobov R; Bamberger E; Schneider S; Esposito S; Tenenbaum T
Clin Microbiol Infect; 2022 May; 28(5):723-730. PubMed ID: 34768022
[TBL] [Abstract][Full Text] [Related]
20. Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children.
Halminen M; Ilonen J; Julkunen I; Ruuskanen O; Simell O; Mäkelä MJ
Pediatr Res; 1997 May; 41(5):647-50. PubMed ID: 9128286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
